{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:43:03Z","timestamp":1788500583640,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.bioorg.2018.09.037","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T21:54:31Z","timestamp":1538430871000},"page":"109-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["1,2,4-Trisubstituted imidazolinones with dual carbonic anhydrase and p38 mitogen-activated protein kinase inhibitory activity"],"prefix":"10.1016","volume":"82","author":[{"given":"Hanan H.","family":"Georgey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma M.","family":"Manhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa R.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehad A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Emanuela","family":"Berrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2018.09.037_b0005","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2018.09.037_b0010","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2018.09.037_b0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use","author":"Pastorek","year":"2015","journal-title":"Semin. Cancer Biol., Elsevier"},{"key":"10.1016\/j.bioorg.2018.09.037_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/metabo7030048","article-title":"Carbonic anhydrase inhibition and the management of hypoxic tumors","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2018.09.037_b0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2018.09.037_b0030","first-page":"404","article-title":"Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target","volume":"2010","author":"De Simone","year":"1804","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2018.09.037_b0035","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.037_b0040","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1021\/jm300529u","article-title":"Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts","volume":"55","author":"Gieling","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.037_b0045","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14756366.2018.1428572","article-title":"Carbon-versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors?","volume":"33","author":"Supuran","year":"2018","journal-title":"J. Enzyme. Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.037_b0050","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.bmc.2011.02.015","article-title":"Purification and inhibition studies with anions and sulfonamides of an \u03b1-carbonic anhydrase from the Antarctic seal Leptonychotes weddellii","volume":"19","author":"Cincinelli","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.037_b0055","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/acsmedchemlett.7b00300","article-title":"Lucky switcheroo: dramatic potency and selectivity improvement of imidazoline inhibitors of human carbonic anhydrase VII","volume":"8","author":"Kalinin","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.09.037_b0060","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1080\/15384047.2016.1177676","article-title":"The p38 MAPK inhibitor BIRB796 enhances the antitumor effects of VX680 in cervical cancer","volume":"17","author":"Jin","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bioorg.2018.09.037_b0065","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbapap.2005.08.017","article-title":"MAPK signalling pathways as molecular targets for anti-inflammatory therapy-From molecular mechanisms to therapeutic benefits","volume":"1754","author":"Kaminska","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2018.09.037_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2011.11.019","article-title":"Structure-based design, synthesis and biological evaluation of N-pyrazole, N'-thiazole urea inhibitors of MAP kinase p38\u03b1","volume":"48","author":"Getlik","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.037_b0075","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1021\/jm049575n","article-title":"Identification of novel p38\u03b1MAP kinase inhibitors using fragment-based lead generation","volume":"48","author":"Gill","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.037_b0080","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1021\/jm9805236","article-title":"Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase","volume":"42","author":"Liverton","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.037_b0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ejmech.2015.03.008","article-title":"Design and synthesis of potent 1,2,4-trisubstituted imidazolinone derivatives with dual p38\u03b1MAPK and ERK1\/2 inhibitory activity","volume":"94","author":"Awadallah","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.037_b0090","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1039\/c3ob27449g","article-title":"Azastilbenes: a cut-off to p38 MAPK inhibitors","volume":"11","author":"Poon","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2018.09.037_b0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbaexp.2005.03.003","article-title":"MAPK pathway contributes to density-and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX","volume":"1729","author":"Kopaceka","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2018.09.037_b0100","article-title":"The synthesis of some acylglycines and related oxazolones","author":"Booth","year":"1960","journal-title":"J. Chem. Soc."},{"key":"10.1016\/j.bioorg.2018.09.037_b0105","first-page":"932","article-title":"Synthesis and study of some compounds containing oxazolone ring, showing biological activity","volume":"47","author":"Tandel","year":"2008","journal-title":"Indian J. Chem. \u2013 Sect. B Org Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.037_b0110","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12039-011-0079-2","article-title":"Design, synthesis and antidiabetic evaluation of oxazolone derivatives","volume":"123","author":"Mariappan","year":"2011","journal-title":"J. Chem. Sci."},{"key":"10.1016\/j.bioorg.2018.09.037_b0115","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00044-016-1566-2","article-title":"Synthesis and biological testing of (5Z)-2-aryl-5-arylmethylidene-3,5-dihydro-4H-imidazol-4-ones as antimitotic agents","volume":"25","author":"Beloglazkina","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2018.09.037_b0120","first-page":"85","article-title":"Synthesis, computational studies and preliminary pharmacological evaluation of new acetamides: potential antipsychotics","volume":"4","author":"Tomar","year":"2012","journal-title":"Der Pharma Chem."},{"key":"10.1016\/j.bioorg.2018.09.037_b0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11164-011-0327-6","article-title":"A facile and efficient method for the selective deacylation of N-arylacetamides and 2-chloro-N-arylacetamides catalyzed by SOCl2","volume":"38","author":"Wang","year":"2012","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.bioorg.2018.09.037_b0130","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1515\/bchm.1998.379.8-9.1101","article-title":"Enzyme-linked immunosorbent assay for measurement of JNK, ERK, and p38 kinase activities","volume":"379","author":"Forrer","year":"1998","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bioorg.2018.09.037_b0135","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818309684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818309684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T15:06:55Z","timestamp":1693926415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818309684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":27,"alternative-id":["S0045206818309684"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.09.037","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1,2,4-Trisubstituted imidazolinones with dual carbonic anhydrase and p38 mitogen-activated protein kinase inhibitory activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.09.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}